Driving Performance in Adolescents With Autism vs. Neurotypical Teens
Official title: A Comparative Study of Driving Performance Among Adolescents With Autism Spectrum Disorder and Neurotypical Adolescents
Run by Hopital La Musse · NCT07630298 · Data updated 2026-11-12
This study tests whether teens with autism make more driving errors than neurotypical teens after limited practice, using a driving simulator and a real-road assessment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 17 Years |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Hopital La Musse Academic / other |
| Locations | 1 site (Saint-Sébastien-de-Morsent) |
| Status | Recruiting |
| Started | October 5, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07630298 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents aged 15 to 17 with ASD and no intellectual disability, limited prior driving (<5 hours), who have passed the written license exam and are enrolled in the social security system.
✕Probably not a fit
Teens with comorbid conditions like ADHD/ODD or those who already hold a driver's license may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study compares novice drivers (less than 5 hours of instruction) with autism to neurotypical peers using a standardized driving simulator and an on-road TRIP assessment. It examines visual strategies, types of errors, and overall driving performance metrics such as speed, reaction time, following distance, and braking. It also evaluates the consistency between simulator results and real-world driving and measures anxiety during simulator drives. Participants are adolescents aged 15–17 who meet specific diagnostic and educational criteria and are enrolled in the social security system.
Why it matters
Potential benefit: If successful, findings could inform targeted training strategies to improve driving safety for teens with ASD.
How similar studies have gone: Prior studies in driving performance and ASD have shown detectable differences in simulator tasks, supporting the rationale for this comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: ASD Group * Adolescents aged 15 to 17, * With a confirmed diagnosis of ASD by a physician, * Without an intellectual disability, with a Fluid Reasoning Index (IRF) greater than 80, * Who have passed the written driver's license exam, * With no or very limited driving experience (\<5 hours), * Enrolled in the social security system. Neurotypical group: * Adolescents aged 15 to 17, * Without a diagnosis of neurodevelopmental disorders or learning disabilities, * With a standard educational background, * Who have passed the written driver's license exam, * With no or very limited driving experience (\<5 hours), * Enrolled in the social security system. Exclusion Criteria: * Adolescents with ADHD (attention-deficit/hyperactivity disorder) and/or ODD (oppositional defiant disorder) and/or IDD (intellectual disability) and/or SLI (specific language impairment) with associated comprehension difficulties, * Adolescents who already have a driver's license, * Adolescents currently taking driving lessons and/or with more than 5 hours of driving experience, * Adolescents who have suffered a head injury during childhood, * Other serious medical conditions that may interfere with participation in the sessions, * Participation in another research protocol.
Where it's running
-
Hôpital La Musse
Saint-Sébastien-de-Morsent, France Recruiting
Study contacts
- Study coordinator: Héloïse BAILLET, Dr
- Email: h.baillet@hlrs-lamusse.net
- Phone: +33232293047
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Arbaclofen for Autism Spectrum Disorders: a crossover and open-label study in children and adolescents
This study tests arbaclofen versus placebo in children and teens with autism to see if the drug affects brain metrics and improves social, adaptive, and quality-of-life outcomes.
-
Collaborative tools to set priorities, support shared decisions, and track quality of life for children with autism
This pilot will try combining new and existing questionnaires to track quality of life, overall functioning, and needs in children with autism under 12 who are receiving usual care.
-
AquOTic water-safety and swim-skills program for children with autism
This 10-week occupational therapy–led program will try to improve water safety and swimming skills in children aged 5–9 on the autism spectrum by comparing delivery by student professionals versus trained community interventionists.
-
Intestinal permeability testing in children with autism
This tests whether children with autism have a leakier gut than their unaffected siblings by having them drink a sugar mix and collecting urine for measurement.
-
Prednisone in adults with an immune-related subtype of autism
This study tests whether prednisone, an anti-inflammatory drug, can help adults with a specific immune-related form of autism compared to a placebo.
-
A system for diagnosing and treating children's brain diseases using advanced technology
This study is testing a new system that uses advanced technology to help doctors diagnose and treat different brain diseases in children, like ADHD and autism, by combining ideas from both Chinese and Western medicine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.